血液生物标志物可预测心血管疾病
|
By LabMedica International staff writers Posted on 04 Jul 2010 |
|
一种简单的血检可帮助识别出有心脏病风险的病人的血管炎症问题。
血液中发现的一种酶绝大部分会与低密度脂蛋白(LDL)结合，可作为冠状动脉血管疾病的风险因素给出指示。脂蛋白相关的磷脂A2 (Lp-PLA2)的活性上升经常会导致动脉硬化，脂蛋白相关的磷脂A2也被称为血小板活化因子乙酰水解酶(PAF-AH)。它被认为是脂肪斑恶化和破裂的关键，脂肪斑会堵塞冠状动脉血管，导致心脏病发作。
LpPLA2的活性和质量在进行动脉X光摄影（血管造影）的高危病人身上进行衡量，动脉X光摄影是一种医疗成像技术，可以看见血管和心室的内腔。有336名白种人和224名非裔美国人参与了研究。
研究结果显示，LpPLA2活性在患有冠状动脉心脏疾病的白人和非裔美国人身上都增加了，不过只有后者的LpPLA2指数可以独立预测冠状动脉血管疾病。
"动脉X光摄影是高度有效的，不过作为普通筛查被认为是太危险，而且费用高，加州大学戴维斯分校(UC Davis, Sacramento, CA, USA; www.ucdmc.ucdavis.edu)首席科学家Lars Berglund医生说。所以，可以可靠预测心脏病发作的简单血检方法会比创伤性过程更易被采用。LpPLA2检测已经被广泛采用，关于这种酶以及针对更大范围人群的其他炎症成份的进一步研究将使得科学家们能够诊断并预测出不同种族和不同民族的心脏病。
研究公布在2010年《临床内分泌学和代谢杂志》上。研究中所提供的信息将使医生们能够针对病人特殊需要进行治疗。
Related Links:
加州大学戴维斯分校>>> www.ucdmc.ucdavis.edu
血液中发现的一种酶绝大部分会与低密度脂蛋白(LDL)结合，可作为冠状动脉血管疾病的风险因素给出指示。脂蛋白相关的磷脂A2 (Lp-PLA2)的活性上升经常会导致动脉硬化，脂蛋白相关的磷脂A2也被称为血小板活化因子乙酰水解酶(PAF-AH)。它被认为是脂肪斑恶化和破裂的关键，脂肪斑会堵塞冠状动脉血管，导致心脏病发作。
LpPLA2的活性和质量在进行动脉X光摄影（血管造影）的高危病人身上进行衡量，动脉X光摄影是一种医疗成像技术，可以看见血管和心室的内腔。有336名白种人和224名非裔美国人参与了研究。
研究结果显示，LpPLA2活性在患有冠状动脉心脏疾病的白人和非裔美国人身上都增加了，不过只有后者的LpPLA2指数可以独立预测冠状动脉血管疾病。
"动脉X光摄影是高度有效的，不过作为普通筛查被认为是太危险，而且费用高，加州大学戴维斯分校(UC Davis, Sacramento, CA, USA; www.ucdmc.ucdavis.edu)首席科学家Lars Berglund医生说。所以，可以可靠预测心脏病发作的简单血检方法会比创伤性过程更易被采用。LpPLA2检测已经被广泛采用，关于这种酶以及针对更大范围人群的其他炎症成份的进一步研究将使得科学家们能够诊断并预测出不同种族和不同民族的心脏病。
研究公布在2010年《临床内分泌学和代谢杂志》上。研究中所提供的信息将使医生们能够针对病人特殊需要进行治疗。
Related Links:
加州大学戴维斯分校>>> www.ucdmc.ucdavis.edu
Gold Member
Hybrid Pipette
SWITCH
ESR Analyzer
TEST1 2.0
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Latest 血液学 News
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read more
Molecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channel
Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more
Microbiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more
AI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read more
Pathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read more
Technology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read more
Aptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channel
New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more